BOTH Stock Chart & Stats
$1.25
$0.00(0.00%)
At close: 4:00 PM EST
$1.25
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1.25 - $1.25
Previous CloseN/A
Volume1.00
Average Volume (3M)0.00
Market Cap
$18.36K
Enterprise Value$589.38K
Total Cash (Recent Filing)$14.66K
Total Debt (Recent Filing)$585.69K
Price to Earnings (P/E)―
Beta-6.77
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding3,600,194
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)-1.84
Price to Sales (P/S)0.00
P/FCF Ratio-11.41
Enterprise Value/Market Cap32.10
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-17.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bioethics News
BOTH FAQ
What was Bioethics’s price range in the past 12 months?
Bioethics lowest stock price was $1.25 and its highest was $1.25 in the past 12 months.
What is Bioethics’s market cap?
Bioethics’s market cap is $18.36K.
When is Bioethics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioethics’s earnings last quarter?
Currently, no data Available
Is Bioethics overvalued?
According to Wall Street analysts Bioethics’s price is currently Overvalued.
Does Bioethics pay dividends?
Bioethics does not currently pay dividends.
What is Bioethics’s EPS estimate?
Bioethics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioethics have?
Bioethics has 3,600,194 shares outstanding.
What happened to Bioethics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bioethics?
Currently, no hedge funds are holding shares in BOTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bioethics
Established in 1990 and located in Ogden, Utah, Bioethics, Ltd. is not currently involved in substantial business activities. Instead, the company plans to explore, assess, and, if appropriate, acquire a stake in a new commercial enterprise.
BOTH Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Bold Eagle Acquisition Corp. Class A
―
Oaktree Acquisition Corp. III Life Sciences Class A
―
Translational Development Acquisition Corp.
―
Republic Digital Acquisition Company Class A
―
Vendome Acquisition Corporation I Class A
―

